Long non-coding RNAs in Alzheimer's disease

Area of Science:

• Neuroscience
• Genomics
• Molecular Biology

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia worldwide.
• Current treatments for dementia, including AD, are not curative.
• Advances in RNA sequencing have revealed the significance of non-protein coding RNAs, such as long non-coding RNAs (lncRNAs).

Purpose of the Study:

• To review the emerging roles of lncRNAs in the pathology of Alzheimer's disease.
• To provide an lncRNA-centric perspective on AD pathogenesis.
• To explore the potential of lncRNAs as prognostic markers and therapeutic targets for AD.

Main Methods:

• Review of current literature on lncRNAs and Alzheimer's disease.
• Analysis of studies reporting brain-specific expression and dysregulation of lncRNAs in AD patients and animal models.
• Synthesis of findings to connect lncRNA functions with pathological features of AD.

Main Results:

• lncRNAs are involved in various biological processes and function as regulatory molecules.
• lncRNA expression is notably brain-specific and altered in Alzheimer's disease.
• Dysregulated lncRNAs are implicated in the pathological mechanisms underlying AD.

Conclusions:

• lncRNAs represent a significant area of research in Alzheimer's disease.
• Their dysregulation in AD suggests a crucial role in disease progression.
• lncRNAs offer promising avenues for novel prognostic markers and therapeutic strategies for AD.